These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 6673978)
21. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone]. Mugler A Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):33-9. PubMed ID: 5549166 [No Abstract] [Full Text] [Related]
22. [Effect of Prolixan 300 (Azapropazone) on the course of rheumatoid disease and degenerative joint disease. Comparison with indomethacin by means of a double blind test]. Kawenoki-Minc E; Gburek Z; Sadkiewicz S; Keller B; Piotrowska E; Rajpert D; Reszkowska H Reumatologia; 1979; 17(3):365-74. PubMed ID: 390661 [No Abstract] [Full Text] [Related]
23. A comparative pilot study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter's disease. Lassus A Curr Med Res Opin; 1976; 4(1):65-9. PubMed ID: 770082 [TBL] [Abstract][Full Text] [Related]
24. [Efficacy and tolerance of azapropazone in comparison with pirprofen in arthrosis]. Palma S; Guzmán L Rev Med Chil; 1987 Jun; 115(6):556-60. PubMed ID: 3331021 [No Abstract] [Full Text] [Related]
25. Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone. Yu TF J Rheumatol; 1976 Sep; 3(3):305-12. PubMed ID: 978666 [TBL] [Abstract][Full Text] [Related]
26. [Current etiopathogenetic and therapeutic views concerning gout and hyperuremic syndromes]. Ravera M Minerva Med; 1973 Jan; 64(4):144-56. PubMed ID: 4686682 [No Abstract] [Full Text] [Related]
27. An assessment of the therapeutic potential of azapropazone in rheumatoid arthritis. Brooks PM; Mason DI; McNeil R; Anderson JA; Buchanan WW Curr Med Res Opin; 1976; 4(1):50-6. PubMed ID: 770080 [TBL] [Abstract][Full Text] [Related]
28. Azapropazone compared with indomethacin in the treatment of rheumatoid arthritis. Hicklin JA; Hingorani K; Lloyd KN; Templeton JS; Wilkinson M Practitioner; 1976 Nov; 217(1301):799-803. PubMed ID: 792863 [No Abstract] [Full Text] [Related]
29. Hypouricemic action of diflunisal in gouty patients: in vitro and in vivo studies. Ferraccioli G; Spisni A; Ambanelli U J Rheumatol; 1984 Jun; 11(3):330-2. PubMed ID: 6547486 [TBL] [Abstract][Full Text] [Related]
30. The diagnosis and management of gouty arthritis. Edwards NL Compr Ther; 1983 Sep; 9(9):14-9. PubMed ID: 6627900 [No Abstract] [Full Text] [Related]
31. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients. Hanvivadhanakul P; Akkasilpa S; Deesomchok U J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443 [TBL] [Abstract][Full Text] [Related]
32. Emerging therapies in the long-term management of hyperuricaemia and gout. Stamp LK; O'Donnell JL; Chapman PT Intern Med J; 2007 Apr; 37(4):258-66. PubMed ID: 17388867 [TBL] [Abstract][Full Text] [Related]
34. [Double-blind trial: ketoprofen versus phenylbutazone in acute gouty arthritis (author's transl)]. Siegmeth W; Placheta P Wien Klin Wochenschr; 1976 Sep; 88(16):535-7. PubMed ID: 793186 [TBL] [Abstract][Full Text] [Related]
35. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Caspi D; Lubart E; Graff E; Habot B; Yaron M; Segal R Arthritis Rheum; 2000 Jan; 43(1):103-8. PubMed ID: 10643705 [TBL] [Abstract][Full Text] [Related]
36. Updates in the management of gout. Keith MP; Gilliland WR Am J Med; 2007 Mar; 120(3):221-4. PubMed ID: 17349440 [TBL] [Abstract][Full Text] [Related]
37. Management of gouty arthritis and hyperuricemia. Owen DS; Toone EC; Irby R GP; 1968 Oct; 38(4):133-8. PubMed ID: 5679519 [No Abstract] [Full Text] [Related]
38. [Arresting an acute attack of gout. Open pilot study in 98 patients]. Bodem H Fortschr Med; 1985 Feb; 103(SPEC NO 7A):203-6. PubMed ID: 3872833 [No Abstract] [Full Text] [Related]
39. Long-term use of azapropazone in rheumatoid conditions. Thune S Curr Med Res Opin; 1976; 4(1):80-8. PubMed ID: 1261301 [TBL] [Abstract][Full Text] [Related]
40. Effect of treatment on erythrocyte phosphoribosyl pyrophosphate synthetase and glutathione reductase activity in patients with primary gout. Braven J; Hardwell TR; Hickling P; Whittaker M Ann Rheum Dis; 1986 Nov; 45(11):941-4. PubMed ID: 3024593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]